Glucose injection

[Pharmacology and Toxicology] Glucose is one of the main sources of calories for the human body. Sodium and chloride are important electrolytes in the body, mainly present in the extracellular fluid, and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body. [Pharmacokinetics] After glucose enters the human body, the normal human body can utilize 6 mg/kg per minute.

This product is a compound preparation containing 5% glucose and 0.9% sodium chloride.

This product is a colorless clear liquid.

Replenish heat energy and body fluids. Used for insufficient food intake or large amount of body fluid loss caused by various reasons.

The usage and dosage of glucose and sodium chloride should be considered at the same time: 1. Usage and dosage of glucose: 1. Supplementation of heat energy When patients eat less or cannot eat for some reason, they can generally be given 10% to 25% glucose injection intravenous drip, and replenish body fluids at the same time. The amount of glucose is calculated based on the required heat energy. 2. Total intravenous nutrition therapy Glucose is the most important energy supply substance for this therapy. In non-protein heat energy, the ratio of glucose to fat heat supply is 2:1. The specific dosage is determined by the clinical heat requirement. According to the need for fluid replacement, glucose can be prepared into different concentrations of 25% to 50%, and insulin can be added if necessary. Add 1 unit of regular insulin for every 5 to 10g of glucose.

1. Excessive and rapid infusion can cause water and sodium retention, resulting in edema, increased blood pressure, increased heart rate, chest tightness, dyspnea, and even acute left heart failure. 2. Improper administration of hypertonic sodium chloride can cause hypernatremia. 3. Excessive and rapid administration of hypotonic sodium chloride can cause hemolysis, cerebral edema, etc. 4. Phlebitis: occurs when hypertonic glucose injection is infused. The incidence of phlebitis decreases when large vein infusion is used instead. 5. Extravasation of high-concentration solution injection can cause local swelling and pain. 6. Reactive hypoglycemia: occurs when combined with excessive use of insulin, the original tendency to hypoglycemia, and when total intravenous nutrition therapy is suddenly stopped. 7. Hyperglycemic non-ketotic coma: often seen in patients with diabetes, stress, use of large doses of glucocorticoids, and uremia peritoneal dialysis patients who are given hypertonic glucose solution and total intravenous nutrition therapy intraperitoneally. 8. Electrolyte imbalance: hypokalemia, hyponatremia, and hypophosphatemia are prone to occur when glucose is simply supplemented for a long time.

(1) Patients with brain, kidney, and heart dysfunction; (2) Patients with low plasma protein; (3) Patients with uncontrolled diabetes and ketoacidosis; (4) Patients with hyperosmotic dehydration; (5) Patients with hyperglycemia and non-hyperosmotic state.

Not yet clear.

Keep tightly closed.

500ml:25g

Shandong Hualu Pharmaceutical Co., Ltd.

• Founded in:

  1998-11-28

• Address:

  No. 1 Hualu Street, Zhenxing Street, Chiping District, Liaocheng City, Shandong Province

• Tax NO.:

  91371523168091268M

• Registered Funds:

  50 million yuan

• Website:

  Log in to view

• Email:

  Log in to view